Oct 28HHS draft policy lets licensed pharmacies compound six peptides, including BPC-157. What changed and what did not.
Skip to content
PeptideAgent

Are peptides legal in Pennsylvania?

By the PeptideAgent Editorial Team. Editorially reviewed, not clinically reviewed.  Last verified

The short answer

Yes. A Pennsylvania resident can obtain FDA approved peptides such as semaglutide and tirzepatide from any Pennsylvania-licensed prescriber, including through telemedicine, which the Department of State says licensees may use within their scope of practice, and can obtain a compounded peptide when it is eligible under federal 503A rules and dispensed by a pharmacy that holds a Pennsylvania pharmacy permit or a Pennsylvania nonresident pharmacy registration from the State Board of Pharmacy. Pennsylvania has no state bulks list, so eligibility of a peptide for compounding follows the FDA framework, and the Board's regulations in 49 Pa. Code chapter 27 govern how Pennsylvania pharmacies compound.

Regulatory: Telehealth allowedRegulatory: Async unclearRegulatory: Compounded GLP-1 limitedVerified: Verified Oct 28, 2026
Compounding rules
Follows the federal 503A framework
Telehealth prescribing
Allowed, asynchronous unclear
Compounded GLP-1
Limited

Can a Pennsylvania resident get peptides by telehealth?

Act 42 of 2024 (Senate Bill 739, approved July 3, 2024, effective 90 days later) added chapter 48 to the insurance title, 40 Pa.C.S. It defines telemedicine to include synchronous interactions, asynchronous interactions (information exchanged other than in real time, including self-reported medical history), and remote patient monitoring. It requires insurers to cover telemedicine for policies filed, issued or renewed 180 days after the effective date, and Medical Assistance and CHIP managed care plans to cover it beginning January 1, 2026. It says a provider delivering care through telemedicine is held to the same standard of care as in person. It is a coverage law and has no provision on establishing a patient relationship or prescribing. The Department of State says licensees may provide services by telemedicine within their scope of practice and accepted standards of care, and that the practice acts and board regulations do not currently address telemedicine. The prescriber must hold a Pennsylvania license. None of the peptides in this database are controlled substances. This record leaves asynchronous prescribing unresolved because Pennsylvania practice law is silent on modality: the only text that mentions asynchronous care is an insurance chapter, which does not by itself authorize asynchronous prescribing. [2] [3]

How does the Pennsylvania pharmacy board treat compounding?

Compounding regulator for Pennsylvania
BoardPennsylvania State Board of Pharmacy (Department of State, Bureau of Professional and Occupational Affairs)
Eligible substancesFollows the federal 503A framework

The State Board of Pharmacy licenses pharmacies under the Pharmacy Act (63 P.S. section 390-1 and following) and regulates practice through 49 Pa. Code chapter 27. The compounding rules at 49 Pa. Code sections 27.601 to 27.606 (effective June 22, 2019) require sterile and non-sterile compounding to follow section 503A of the federal Food, Drug, and Cosmetic Act, its regulations, and the current USP compounding chapters; section 27.602 bars pharmacists from compounding drugs FDA has withdrawn for safety or effectiveness, essentially copies of commercially available drugs except as 503A allows, and drugs FDA has identified as not compoundable. Pennsylvania has not adopted a separate list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). Section 4.1 of the Pharmacy Act (63 P.S. section 390-4.1, added in 2015) requires a nonresident pharmacy to register with the Board every two years, hold a valid home-state license, submit its most recent home-state or national inspection report, and provide a toll-free pharmacist line, and it bars shipping legend drugs into Pennsylvania without that certificate of registration. The Board's license verification confirms registration. [1] [5] [6] [8]

Can you get compounded GLP-1s in Pennsylvania?

Regulatory: Compounded GLP-1 limited

Telehealth GLP-1 patients should confirm the dispensing pharmacy holds a Pennsylvania pharmacy permit or nonresident pharmacy registration. [1] [11]

Prices by channel: semaglutide cost, tirzepatide cost.

Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.

What is the legal access path in Pennsylvania?

Access options

We may earn a commission from these links.

Prices are the partner's own and are not verified by PeptideAgent. You answer health questions after checkout, and the partner's clinician decides whether to prescribe.

Unsponsored access paths are checked against public regulatory records. Sponsored offers are the partner's and are labeled. Products labeled research use only are never listed.

Find a provider in Pennsylvania

What you'll actually find in Pennsylvania, and how to check

Licensed compounding pharmacies, clinics, and telehealth prescribers openly offer many unapproved peptides, and prescribers write prescriptions for them. [16] [17] [18]

No FDA oversight of the specific product: FDA does not check a compounded drug's safety, effectiveness, or quality before it is sold. [19]

What Pennsylvania has done

PeptideAgent has not found a board or legislative action on peptides in Pennsylvania.

Other states have acted:

  • On August 19, 2026, Mississippi's medical, nursing, and pharmacy boards said no licensed provider may prescribe, recommend, supply, or administer a peptide that is not FDA approved, and that a consent form does not remove the provider's liability. [21] Mississippi law
  • Louisiana acted by statute: Act 374, in effect August 1, 2026, bars its licensing boards from prohibiting peptides only when they come from a pharmacy or outsourcing facility that complies with federal compounding law. It does not make any peptide eligible to compound. [22] [23] Louisiana law

Checking the prescriber

Telehealth prescribing of non-controlled peptides is permitted in Pennsylvania. The state law we checked does not settle whether a prescription can be issued without a live visit, so expect one. [2] [3] The telehealth rule in full.

Checking the pharmacy

Look the pharmacy up yourself before you pay, including an out-of-state mail-order pharmacy. The pharmacy regulator is the Pennsylvania State Board of Pharmacy (Department of State, Bureau of Professional and Occupational Affairs); its license search: FDA BeSafeRx: state board of pharmacy license lookups. [20]

If you're going ahead anyway

These steps lower some risks. They do not make a compounded product safe, and FDA has not reviewed it. [19]

They do not change a peptide's legal status either. That depends on the peptide: for a withdrawn nomination such as BPC-157 or TB-500, a 503A pharmacy has no federal basis to compound it from bulk, with or without a prescription, while a few Category 1 substances, such as NAD+ and glutathione, are compounded under FDA's interim policy, with conditions. Each peptide page gives its status. [9] [24] [25]

Check the pharmacy's license. Look the pharmacy up yourself on your state board of pharmacy's license search; FDA's BeSafeRx page links every state's. If the pharmacy is not listed, or is not licensed in your state, do not use it. [20] [26] [27]

What a legitimate prescription and consult look like. Federal law lets a pharmacy compound only for an identified patient on a valid prescription. A legitimate prescriber is licensed in the state where you are, evaluates you, and tells you the drug is compounded and not FDA approved, and a telehealth company should say which pharmacy compounds it. A seller that needs no prescription, or a pharmacy with no pharmacist to answer questions, is a warning sign. [18] [27] [28]

Why this is safer than a research-use-only product. A state-licensed pharmacy answers to its state board and has a pharmacist you can reach. A product labeled "research use only" or "not for human consumption" has neither, and FDA treats such products sold for people as unapproved drugs. In a 2024 study of semaglutide sold online without a prescription, half of six orders never arrived, and every vial that did was rated probably substandard or falsified, held more drug than its label said, and contained endotoxin. Black-market growth peptides have also contained modified molecules the label did not name. Safer is not safe: compounded drugs can also be contaminated or have too much or too little active ingredient. [19] [29] [30] [31] [32] [33]

Check for:

  • A 503A pharmacy licensed in your state (your state board of pharmacy publishes license lookups). [19]
  • A real evaluation by a licensed prescriber, not just an online form.
  • A certificate of analysis for the specific batch.

Questions to ask

  • Pharmacy: What is your license number, and are you licensed in my state? Then check it yourself on the state board's site. [20]
  • Telehealth company: Which pharmacy compounds and ships this, and is it a 503A pharmacy or a 503B outsourcing facility? [18]
  • Pharmacy: Is this made for me on a prescription written in my name? [28]
  • Prescriber: Are you licensed where I am, and will you evaluate me yourself rather than rely on a questionnaire? [18] [27]
  • Anyone offering it: Does anyone call it "FDA approved", "generic", or from an "FDA-approved pharmacy"? None of these is true of a compounded drug, so the claim is a red flag. [18]

What is offered for a specific peptide, and what FDA found, is on each peptide page.

Is it legal to buy research peptides in Pennsylvania?

The Pennsylvania Pharmacy Act restricts dispensing of prescription drugs to licensed pharmacies, and the Controlled Substance, Drug, Device and Cosmetic Act (35 P.S. section 780-101 and following) prohibits the sale of adulterated, misbranded, or unapproved new drugs in the Commonwealth. [5] [7] [12]

Peptide-specific notes for Pennsylvania

No peptide-specific rule identified for this jurisdiction. The general compounding and telehealth rules above apply, and the federal record covers semaglutide, tirzepatide, and BPC-157.

Frequently asked questions

Can I get a GLP-1 prescription in Pennsylvania through telemedicine?

Yes, from a Pennsylvania-licensed prescriber. The Department of State says licensees may provide services by telemedicine within their scope of practice and accepted standards of care. Pennsylvania law does not settle whether a prescription can be issued without a live visit. The practice acts and board regulations do not address telemedicine, and Act 42 of 2024, which mentions asynchronous care, is an insurance coverage law with no prescribing provision. [2] [3]

Does the telemedicine prescriber need a Pennsylvania license?

Yes. The Department of State's telemedicine guidance speaks to Pennsylvania licensees practicing within their scope of practice. Physicians in other states can obtain a Pennsylvania license through the Interstate Medical Licensure Compact via the State Board of Medicine. Verify the prescriber in the Department of State license lookup before paying. [3] [4] [13]

Can an out-of-state pharmacy ship compounded peptides to me in Pennsylvania?

Only if it holds a certificate of registration from the Pennsylvania State Board of Pharmacy as a nonresident pharmacy. Section 4.1 of the Pharmacy Act (63 P.S. section 390-4.1) bars a nonresident pharmacy from shipping legend drugs into Pennsylvania without one. Search the Department of State license verification for the pharmacy name; if it is not registered, the shipment is not lawful in Pennsylvania even if the prescriber is compliant. [1] [5]

Can a Pennsylvania pharmacy compound BPC-157 or other unapproved peptides?

Only under a draft federal policy, and only within strict limits. On October 28, 2026 HHS released a draft enforcement discretion policy saying it will not take enforcement action against a state-licensed pharmacy that compounds BPC-157 as a single-ingredient product by an allowed route, on a patient-specific prescription, from an FDA-registered manufacturer's substance with a tested certificate of analysis, with serious adverse events reported to FDA. BPC-157 is still not FDA approved or on the 503A bulks list, the policy is not binding and HHS may revisit it, and blends such as Wolverine are not covered. FDA's drug center recommended against listing BPC-157; the advisory committee voted in favor (HHS policy, Appendix B). The draft covers only six single peptides (BPC-157, epitalon, KPV, MOTS-c, semax, TB-500); others, such as CJC-1295 and ipamorelin, are not covered. State law still applies: Pennsylvania has not adopted a separate list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test. [6] [9] [10] [14] [15]

Sources

Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, federal FDA guidance, and the FDA warning letters and studies behind what is offered.

  1. [1]Pennsylvania State Board of Pharmacy
  2. [2]Pennsylvania Act 42 of 2024 (Senate Bill 739), 40 Pa.C.S. chapter 48, Telemedicine (full text)
  3. [3]Pennsylvania Department of State: Telemedicine FAQs
  4. [4]Pennsylvania State Board of Medicine (licensure and Interstate Medical Licensure Compact)
  5. [5]Pennsylvania Pharmacy Act, Act of Sept. 27, 1961, P.L. 1700, No. 699 (63 P.S. section 390-1 and following), including section 4.1, Nonresident pharmacies
  6. [6]49 Pa. Code chapter 27, State Board of Pharmacy regulations (compounding, sections 27.601 to 27.606)
  7. [7]Pennsylvania Controlled Substance, Drug, Device and Cosmetic Act, 35 P.S. section 780-101 and following (Act 1972-64)
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  10. [10]FDA: Pharmacy Compounding Advisory CommitteeFDA

Cite this page

Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.

APA style
PeptideAgent. (2026, October 28). Are peptides legal in Pennsylvania?. https://peptideagent.ai/legal/pennsylvania
HTML link
<a href="https://peptideagent.ai/legal/pennsylvania">Are peptides legal in Pennsylvania?</a>, PeptideAgent, updated October 28, 2026.